hackint0sh/New-Dataset huggingface dataset:
nctId: NCT06294444 id: REC/RCR&AHS/23/0741 briefTitle: Comparison of Constraint Induced Movement Therapy and Mirror Therapy overallStatus: RECRUITING date: 2023-12-01 date: 2024-03-15 date: 2024-03-15 date: 2024-03-05 date: 2024-03-05 name: Riphah International University class: OTHER briefSummary: Hemiplegia in infants and children is a type of Cerebral Palsy that results from damage to the part (hemisphere) of the brain that controls muscle movements. This damage may occur before, during or shortly after birth. The term hemiplegia means that the paralysis is on one vertical half of the body. The aim of this study will be the to know the effect of mCIMT with and without mirror therapy on upper limb function in children with hemiplegic cerebral palsy. A randomized control trial will be conducted at Sheikh Zayed Hospital, RYK through convenience sampling technique on 30 patients which will be allocated through simple random sampling through sealed opaque enveloped into group A and group B. Group A will be treated with mCIMT and Group B will be treated with mCIMT and mirror therapy. Outcome measure will be conducted through pain and disability questionnaire after 6 weeks. Data will be analyzed using SPSS software version 21. After assessing normality of data by Shapiro - wilk test, it will be decided either parametric or non-parametric test will be used within a group or between two groups. mCIMT with and without mirror therapy will be applied in patients with hemiplegic cerebral palsy to see the effect on upper limb function. conditions: Hemiplegic Cerebral Palsy studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: Randomized Control Trial primaryPurpose: HEALTH_SERVICES_RESEARCH masking: SINGLE maskingDescription: Participants will get separate treatment protocol and possible efforts will be put to mask the both groups about their treatment whoMasked: PARTICIPANT count: 30 type: ESTIMATED name: Constraint Induced Movement Therapy name: Mirror therapy measure: fine motor skills sex: ALL minimumAge: 6 Years maximumAge: 12 Years stdAges: CHILD facility: Imran Amjad status: RECRUITING city: Lahore state: Punjab zip: 54000 country: Pakistan name: Muhammad Asif Javed, MS role: CONTACT phone: 923224209422 email: a.javed@riphah.edu.pk name: Imran Amjad, PhD role: CONTACT phone: 923224390125 email: imran.amjad@riphah.edu.pk name: Hurriya Sehar, MS* role: PRINCIPAL_INVESTIGATOR lat: 31.558 lon: 74.35071 facility: Riphah International University status: RECRUITING city: Lahore state: Punjab country: Pakistan lat: 31.558 lon: 74.35071 hasResults: False
nctId: NCT06294431 id: RADX-P-2406 briefTitle: Radicle Clarity 24: A Study of Health and Wellness Products on Cognitive Function and Related Health Outcomes overallStatus: ACTIVE_NOT_RECRUITING date: 2024-02-22 date: 2024-05 date: 2024-07 date: 2024-03-05 date: 2024-04-24 name: Radicle Science class: INDUSTRY briefSummary: A randomized, double-blind, placebo-controlled direct-to-consumer study of health and wellness products on cognitive function and related health outcomes conditions: Cognitive Function studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: Participants will be stratified based on their gender assigned at birth and health outcome score during enrollment, then randomized to one of the study arms. Each participant will have an equal chance of being assigned to any study arm. primaryPurpose: OTHER masking: DOUBLE maskingDescription: The investigator is blinded to the participants' assigned study products. Participants are blinded to the study product they received. whoMasked: PARTICIPANT whoMasked: INVESTIGATOR count: 1001 type: ESTIMATED name: Placebo Control Form 1 name: Clarity Active Study Product 1.1 Usage name: Placebo Control Form 2 name: Clarity Active Study Product 2.1 Usage measure: Change in cognitive function measure: Change in fatigue measure: Change in sleep-related impairment measure: Minimal clinical importance difference (MCID) in cognitive function measure: Change in mood (emotional distress-depression) measure: Change in concentration of at-home (direct-to-consumer) specimen assays either saliva, blood or stool sex: ALL minimumAge: 21 Years maximumAge: 105 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Radicle Science, Inc city: Del Mar state: California zip: 92014 country: United States lat: 32.95949 lon: -117.26531 hasResults: False
nctId: NCT06294418 id: 1-037-23 briefTitle: FCI in Post-operative Low Grade Gliomas overallStatus: RECRUITING date: 2024-02-15 date: 2025-03 date: 2025-03 date: 2024-03-05 date: 2024-03-05 name: NHS Grampian class: OTHER_GOV name: University of Aberdeen briefSummary: The aim of this pilot study is to explore the utility of a new imaging technique, called Field Cycling Imaging (FCI), in postoperative low grade gliomas.
The main question it aims to answer is if FCI can differentiate subtypes of low grade gliomas. Participants will have one FCI scan. conditions: Glioma studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: BASIC_SCIENCE masking: NONE count: 10 type: ESTIMATED name: Field Cycling Imaging (FCI) measure: Differentiation of sub-types of low grade glioma assessed by Field Cycling Imaging (FCI) T1 dispersion profiles sex: ALL minimumAge: 16 Years stdAges: CHILD stdAges: ADULT stdAges: OLDER_ADULT facility: Aberdeen Royal Infirmary status: RECRUITING city: Aberdeen zip: AB25 2ZD country: United Kingdom name: Arnab K Rana, Dr role: CONTACT phone: +441224438363 email: arnab.rana@abdn.ac.uk lat: 57.14369 lon: -2.09814 hasResults: False
nctId: NCT06294405 id: 24-0010 briefTitle: Intraocular Lens Implant Registry Study overallStatus: RECRUITING date: 2024-02-21 date: 2029-02-14 date: 2029-02-14 date: 2024-03-05 date: 2024-03-05 name: University Hospital Augsburg class: OTHER briefSummary: The goal of this registry study is to optimize the results with intraocular lens implants used in cataract surgery. conditions: Intraocular Lens Complication conditions: Intraocular Lens Rotation conditions: Intraocular Lens Associated Postoperative Inflammation conditions: Lens Opacities studyType: OBSERVATIONAL observationalModel: OTHER timePerspective: OTHER count: 500 type: ESTIMATED name: Intraocular lens Implantation measure: Functional results with different Intraocular lenses measure: Contrast sestivitiy with different Intraocular lenses measure: Anatomical results. sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: University Hospital Augsburg status: RECRUITING city: Augsburg country: Germany name: Isabella Baur, MD role: CONTACT lat: 48.37154 lon: 10.89851 hasResults: False
nctId: NCT06294392 id: 90FA3010 briefTitle: KEEP Connecting Kin acronym: KEEP-CK overallStatus: RECRUITING date: 2024-02-13 date: 2026-04 date: 2026-04 date: 2024-03-05 date: 2024-03-05 name: Oregon Social Learning Center class: OTHER name: Office of Planning, Research & Evaluation briefSummary: The current study provides a unique opportunity to conduct a summative evaluation of the KEEP Connecting Kin (KEEP-CK) program by leveraging extant relationships with Oregon's Child Welfare System (CWS), Self-Sufficiency Program (SSP), and our community partners to address the needs of informal kinship families and the youth in their care. Specifically, a randomized "services-as-usual" (SAU) waitlist control design plus qualitative methods will be used to evaluate the immediate (post-intervention) and sustained (10 month) impacts of the KEEP-CK program on child, adult, and service utilization outcomes, and prevention of entry into the CWS. conditions: Internalizing Behavior conditions: Externalizing Behavior conditions: Child Permanency conditions: Parenting conditions: Parent Stress conditions: Service Utilization studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: Informal kinship caregivers will be randomly assigned to receive the KEEP-CK program either immediately or after waiting 10 months using a randomized blocked design. Blocking factors include: (a) the length of time that the child has been living in informal kinship care (\<=6 months, 7 months to \<2 years, or \>=2 years); (b) child age (4 to 12 years, or 13+ years); and (c) low (or not low) resource families, defined by an annual household income below (or above) 150% of the federal poverty level. primaryPurpose: PREVENTION masking: NONE count: 192 type: ESTIMATED name: KEEP-CK measure: Mean change in youth well-being (i.e., behavioral and emotional functioning, including child internalizing and externalizing behaviors) measure: Mean change in child permanency (i.e., placement stability and permanency of placements) measure: Mean change in parenting practices and parent/caregiver stress. measure: Mean change in parent/caregiver stress. measure: Mean change in parenting practices. measure: Mean change in parents' use of services from multiple systems (financial, educational, mental health, medical, legal) sex: ALL minimumAge: 4 Years maximumAge: 18 Years stdAges: CHILD stdAges: ADULT facility: Oregon Center Learning Center status: RECRUITING city: Eugene state: Oregon zip: 97401 country: United States name: Courtenay Padgett role: CONTACT phone: 541-485-2711 email: CourtP@oslc.org lat: 44.05207 lon: -123.08675 typeAbbrev: SAP hasProtocol: False hasSap: True hasIcf: False label: Statistical Analysis Plan date: 2023-07-11 uploadDate: 2024-02-27T15:36 filename: SAP_000.pdf size: 239212 hasResults: False
nctId: NCT06294379 id: OUH_SDM briefTitle: Shared Decision Making in Melanoma Patients Receiving Adjuvant Therapy overallStatus: RECRUITING date: 2022-03-01 date: 2024-12-30 date: 2024-12-30 date: 2024-03-05 date: 2024-03-05 name: Odense University Hospital class: OTHER name: University of Copenhagen name: Aarhus University Hospital name: Aalborg University Hospital briefSummary: This study aims to develop test and evaluate a Patient Decision Aid called "The Decision Helper" among melanoma patients eligible for adjuvant treatment.
* Are there any differences in the levels of decisional regret in the patients who have not used the Decision Helper (pre-implementation) compared to the ones who have (post-implementation? conditions: Malignant Melanoma studyType: OBSERVATIONAL observationalModel: OTHER timePerspective: RETROSPECTIVE count: 150 type: ESTIMATED measure: Development of a Patient Decision Aid "The Decision Helper" for melanoma patients receiving adjuvant theory measure: Evaluation of the "The Decision Helper" sex: ALL minimumAge: 18 Years maximumAge: 100 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Odense University Hospital status: RECRUITING city: Odense C zip: 5000 country: Denmark name: Lærke Tolstrup role: CONTACT phone: 40295129 email: lctolstrup@mail.dk lat: 55.39594 lon: 10.38831 hasResults: False
nctId: NCT06294366 id: MenoufiaU2022 briefTitle: Bipolar Transurethral Enucleation Versus Resection in the Treatment of Benign Prostatic Hyperplasia: a Comparative Study overallStatus: RECRUITING date: 2022-06-12 date: 2024-04-12 date: 2024-06-12 date: 2024-03-05 date: 2024-03-05 name: Menoufia University class: OTHER briefSummary: Benign prostatic hyperplasia (BPH) is a common chronic progressive disease resulting in the enlargement of the prostate gland and bladder outlet obstruction in aging men .
Transurethral resection of the prostate (TURP) has been recognized as the standard treatment for BPH with morbidity rate varies from 18% and 26% Until now, only open prostatectomy and transurethral Holmium laser enucleation of the prostate (HoLEP) have shown an equal efficacy and durability compared to TURP conditions: Prostatic Hyperplasia conditions: Prostate Enucleation studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: NONE count: 52 type: ESTIMATED name: Bipolar Bowa device measure: Assessing and comparing the safety, the surgical efficacy and peri-operative morbidity of bipolar enucleation of the prostate and bipolar transurethral resection of the prostate for the treatment of patients with symptomatizing prostates. sex: MALE minimumAge: 50 Years maximumAge: 90 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Faculty of medicine status: RECRUITING city: Shibīn Al Kawm state: Menoufia zip: 32866 country: Egypt name: Baher M Abdelraouf, MD role: CONTACT phone: +201069973254 email: maar2002002@gmail.com lat: 30.55258 lon: 31.00904 hasResults: False
nctId: NCT06294353 id: WCTP-ED-B-01 briefTitle: Study of Efficacy and Safety of WELT-ED for Eating Disorder (WCTP-ED-B-01) overallStatus: RECRUITING date: 2023-03-29 date: 2024-06-30 date: 2024-08-30 date: 2024-03-05 date: 2024-03-06 name: WELT corp class: INDUSTRY briefSummary: The purpose of this clinical trial is to evaluate the safety and efficacy of a digital therapeutic device (WELT-ED) based on Cognitive Behavioral Therapy (CBT) for the treatment of eating disorders.
* Participate in assessments to monitor changes in their eating disorder symptoms and any potential side effects. conditions: Eating Disorders conditions: Binge Eating conditions: Binge-Eating Disorder studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: NONE count: 134 type: ESTIMATED name: WELT-ED (CBT based DTx) name: Standard Treatment measure: Binge Eating Frequency measure: Eating Disorder Examination Questionnaire (EDE-Q) measure: Clinical Impairment Assessment (CIA) measure: Patient health questionnaire-9 (PHQ-9) measure: Generalized anxiety disorder 7-item scale (GAD-7) measure: The EuroQol Visual Analogue Scale (EQ-VAS) measure: Clinical Global Impression of Improvement (CGI-I) measure: Clinical Global Impression of Severity (CGI-S) measure: Adherence (Compliance) to WELT-ED (applicable only to WELT-ED Group) measure: BMI (Body Mass Index) measure: WELT-ED App Usage Satisfaction (applicable only to WELT-ED Group) measure: App-Based Lifestyle and Eating Data (applicable only to WELT-ED Group) measure: Change in Regular Meal Frequency (applicable only to WELT-ED Group) sex: ALL minimumAge: 19 Years maximumAge: 65 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Seoul National University Hospital status: RECRUITING city: Seoul zip: 03080 country: Korea, Republic of name: soohee Choi role: CONTACT phone: 0215885700 email: soohchoi@snu.ac.kr lat: 37.566 lon: 126.9784 facility: Severance Hospital status: RECRUITING city: Seoul zip: 03722 country: Korea, Republic of name: Young Chul Jung, MD role: CONTACT phone: 82-2-2228-1622 email: eugenejung@yuhs.ac lat: 37.566 lon: 126.9784 hasResults: False
nctId: NCT06294340 id: 1322-IX/42 briefTitle: Noise, Oxidative Stress and Cardiovascular System acronym: NOXYCARD overallStatus: NOT_YET_RECRUITING date: 2025-01 date: 2027-12 date: 2028-12 date: 2024-03-05 date: 2024-03-05 name: University of Belgrade class: OTHER briefSummary: Environmental noise represents a health problem for at least one in five citizens of the European Union. Noise exposure leads to the development of arterial hypertension, myocardial infarction, stroke, and obesity. Given the limited information on noise exposure and noise effects on humans in the Republic of Serbia, the overall objective of NOXYCARD is to collect environmental noise levels data; to identify long-term and short-term noise effects on the cardiovascular system; and to evaluate the levels of blood stress hormones, oxidative stress, and inflammation in individuals with normal body weight and individuals with obesity. conditions: Noise; Adverse Effect conditions: Noise Exposure studyType: OBSERVATIONAL observationalModel: CASE_CONTROL timePerspective: CROSS_SECTIONAL count: 150 type: ESTIMATED name: Exposure to loud pre-recorded road traffic noise measure: Systolic blood pressure measure: Concentration of stress hormone measure: Diastolic blood pressure measure: Concentration of inflammation parameters sex: ALL minimumAge: 18 Years maximumAge: 65 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Faculty of Medicine, University of Belgrade city: Belgrade state: Beograd zip: 11040 country: Serbia lat: 44.80401 lon: 20.46513 hasResults: False
nctId: NCT06294327 id: EC23027 briefTitle: RESTART the Prevention of Pressure Ulcers: Comparing the Effectiveness and Cost of a Reactive Static Air Mattress and Alternating Air Pressure Mattress overallStatus: RECRUITING date: 2024-01-22 date: 2025-01-01 date: 2025-04-30 date: 2024-03-05 date: 2024-03-07 name: Vitaz class: OTHER name: University Ghent briefSummary: Pressure ulcers are a global issue and substantial concern for healthcare systems. A review of the literature between January 2000 and December 2012 has revealed that prevalence rate of pressure ulcers in aged care facilities were between 4.1% and 32.2%, and the incidence rates ranged from 1.9% to 59%. Similarly, a systematic review reported that the prevalence of pressure ulcer varied between 0.3% and 46%, and the incidence of pressure ulcer ranged from 0.8% to 34%. Most epidemiological data were obtained from hospitals (38.7%) and institutional long-term care facilities (29.7%).
The costs associated with pressure ulcers are considerable. According to the Agency for Healthcare Research \& Quality (2011), the US healthcare system has allocated approximately $ 9.1 - $ 11.6 billion annually for the health care cost of pressure ulcer. In addition to direct treatment-related costs, the development of pressure ulcer also results in litigation and government penalties, and affects hospital performance metrics. A systematic review has reported that the cost for treatment of pressure ulcer was higher than its prevention. That is, the cost per patient per day ranged from € 1.71 to € 470.49 (for treatment) and from € 2.65 to € 87.57 (for prevention) across all settings.
This randomized controlled trial will be performed in a general hospital in a random sample of 308 patients (nursing wards geriatric n=3 and orthopedic (n=3)) who are at high risk of developing pressure ulcers. Patients will be included in the study for a period \> 2 hospitalisation days. Skin assessment and risk factor registration will be done on a daily base by the ward nurses. Reliability checks and time measurements will be completed by the researcher. conditions: Pressure Injury conditions: Pressure Ulcer conditions: Decubitus Ulcer studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: PREVENTION masking: NONE count: 308 type: ESTIMATED name: Reactive static air support surfaces measure: Incidence of pressure ulcer, category > I measure: Cost of alternating air pressure mattress compared to reactive static air support surfaces measure: Patient comfort sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Vitaz (General Hospital) status: RECRUITING city: Sint-Niklaas state: East Flanders zip: 9100 country: Belgium name: Brecht Serraes, PhD role: CONTACT phone: +3237602039 email: Brecht.Serraes@vitaz.be name: Peter Desmet, MD role: CONTACT lat: 51.16509 lon: 4.1437 hasResults: False
nctId: NCT06294314 id: 1982669-3 briefTitle: Return to Play After ACL Reconstruction With Bone Marrow Aspirate, DBM, and an Internal Brace overallStatus: RECRUITING date: 2024-02-26 date: 2026-08-01 date: 2028-07-01 date: 2024-03-05 date: 2024-03-05 name: Marshall University class: OTHER name: Arthrex, Inc. briefSummary: The Investigators are studying the effect of an ACL reconstruction on return to play by capturing outcome measures and biomechanics information. conditions: Anterior Cruciate Ligament Rupture studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 450 type: ESTIMATED name: Fertilized ACL measure: Return to play measure: Biomechanics testing measure: MRI findings measure: Rerupture sex: ALL minimumAge: 14 Years maximumAge: 26 Years stdAges: CHILD stdAges: ADULT facility: Marshall University status: RECRUITING city: Huntington state: West Virginia zip: 25755 country: United States name: chad d lavender, md role: CONTACT phone: 304-552-6514 email: doclav@gmail.com name: Kara Cipriani, np role: CONTACT phone: 304-541-5316 email: cipriani6@marshall.edu lat: 38.41925 lon: -82.44515 hasResults: False
nctId: NCT06294301 id: P10-LP005-01 briefTitle: A Study of Single and Multiple Doses of LP-005 in Healthy Adult Participants overallStatus: RECRUITING date: 2023-11-19 date: 2024-04-30 date: 2024-10-30 date: 2024-03-05 date: 2024-03-05 name: Longbio Pharma class: INDUSTRY briefSummary: The purpose of this study is to evaluate safety, tolerability, immunogenicity, pharmacokinetics, pharmacodynamics, and efficacy of LP-005 in healthy volunteers. The study will be conducted in 2 parts: Part 1, the single ascending dose (SAD) is the first in human (FIH) study of LP-005 and Part 2, multiple ascending dose (MAD). conditions: Paroxysmal Nocturnal Hemoglobinuria (PNH) studyType: INTERVENTIONAL phases: PHASE1 allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: TRIPLE whoMasked: PARTICIPANT whoMasked: CARE_PROVIDER whoMasked: INVESTIGATOR count: 78 type: ESTIMATED name: LP-005 Dose 1 (Single) name: LP-005 Dose 2 (Single) name: LP-005 Dose 3 (Single) name: LP-005 Dose 4 (Single) name: LP-005 Dose 5 (Single) name: LP-005 Dose 6 (Single) name: Placebo (Single) name: LP-005 Dose 7 (Multiple) name: LP-005 Dose 8 (Multiple) name: LP-005 Dose 9 (Multiple) name: Placebo (Multiple) measure: Adverse events measure: Time to peak concentration (Tmax) of LP-005 measure: Maximum concentration (Cmax) of LP-005 measure: Elimination half-life (t1/2) of LP-005 measure: Area under the concentration-time curve (AUC0-t) of LP-005 measure: Apparent clearance rate (CL/F) of LP-005 measure: Assessment of immunogenicity measure: Assessment of complement C5 activity measure: Assessment of complement C3b activity sex: ALL minimumAge: 18 Years maximumAge: 50 Years stdAges: ADULT facility: Shanghai Public Health Clinical Center status: RECRUITING city: Shanghai state: Shanghai country: China name: Yun Ling role: CONTACT lat: 31.22222 lon: 121.45806 hasResults: False
nctId: NCT06294288 id: P-10-LP003-2022-01 briefTitle: A Study of Single and Multiple Doses of LP-003 in Healthy Adult Participants overallStatus: ACTIVE_NOT_RECRUITING date: 2021-07-01 date: 2023-09-03 date: 2024-03-15 date: 2024-03-05 date: 2024-03-05 name: Longbio Pharma class: INDUSTRY briefSummary: The purpose of this study is to evaluate safety, tolerability, immunogenicity, pharmacokinetics, pharmacodynamics, and efficacy of LP-003 in healthy volunteers. The study will be conducted in 2 parts: Part 1, the single ascending dose (SAD) is the first in human (FIH) study of LP-003 and Part 2, multiple ascending dose (MAD). conditions: Chronic Spontaneous Urticaria studyType: INTERVENTIONAL phases: PHASE1 allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: TRIPLE whoMasked: PARTICIPANT whoMasked: CARE_PROVIDER whoMasked: INVESTIGATOR count: 70 type: ESTIMATED name: LP-003 Dose 1 (Single) name: LP-003 Dose 2 (Single) name: LP-003 Dose 3 (Single) name: LP-003 Dose 4 (Single) name: LP-003 Dose 5 (Single) name: Placebo (Single) name: LP-003 Dose 6 (Multiple) name: LP-003 Dose 7 (Multiple) name: LP-003 Dose 8 (Multiple) name: Placebo (Multiple) measure: Adverse events measure: Time to peak concentration (Tmax) of LP-003 measure: Maximum concentration (Cmax) of LP-003 measure: Elimination half-life (t1/2) of LP-003 measure: Area under the concentration-time curve (AUC0-t) of LP-003 measure: Apparent clearance rate (CL/F) of LP-003 measure: Assessment of immunogenicity measure: Assessment of total immunoglobulin E (IgE) measure: Assessment of free IgE sex: ALL minimumAge: 18 Years maximumAge: 50 Years stdAges: ADULT facility: Shanghai General Hospital city: Shanghai state: Shanghai country: China lat: 31.22222 lon: 121.45806 hasResults: False